.
ISSN 2063-5346
-
BIOCHEMISTRY OF FASTING – A REVIEW ON METABOLIC SWITCH AND AUTOPHAGY.
Volume - 13 | Issue-1
-
ONE-POT ENVIRONMENT FRIENDLY SYNTHESIS OF IMINE DERIVATIVE OF FURFURAL AND ASSESSMENT OF ITS ANTIOXIDANT AND ANTIBACTERIAL POTENTIAL
Volume - 13 | Issue-1
-
MODELING AND ANALYSIS OF MEDIA INFLUENCE OF INFORMATION DIFFUSION ON THE SPREAD OF CORONA VIRUS PANDEMIC DISEASE (COVID-19)
Volume - 13 | Issue-1
-
INCIDENCE OF HISTOPATHOLOGICAL FINDINGS IN APPENDECTOMY SPECIMENS IN A TERTIARY CARE HOSPITAL IN TWO-YEAR TIME
Volume - 13 | Issue-1
-
SEVERITY OF URINARY TRACT INFECTION SYMPTOMS AND THE ANTIBIOTIC RESISTANCE IN A TERTIARY CARE CENTRE IN PAKISTAN
Volume - 13 | Issue-1
PHARMACOECONOMIC EVALUATION OF EMPAGLIFLOZIN AS AN ADD-ON THERAPY IN TYPE-2 DIABETES HYPERTENSIVE PATIENTS: A PROSPECTIVE OBSERVATIONAL STUDY
Main Article Content
Abstract
Newer anti-diabetic drugs are predicted to have cardio-renal safety and fewer adverse effects than conventional anti-diabetic drugs, but their high cost is a key barrier to their usage. A prospective observational study involving 200 type 2 diabetes mellitus (T2DM) patients with hypertension who visited Endocrine out-patient clinics of SKIMS, a tertiary care referral hospital. Empagliflozin 25 mg (SGLT-2 inhibitor) was administered as an add-on therapy with metformin, teneligliptin and glimepiride for three months
Article Details
